Variant · Snv
NT5C2 NM_001351169.2(NT5C2):c.1272+73T>G
CI-VAR-00199185Explore in graph →NM_001351169.2:c.1272+73T>GClinVar 1237292 rs34758128
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1237292 | Benign | criteria provided, multiple submitters, no conflicts | 2 | Malignant lymphoma, large B-cell, diffuse; Uterine carcinosarcoma; Thymoma; Cholangiocarcinoma; Uterine corpus endometrial carcinoma | germline | 3 | Jun 26, 2018 | clinvar |